- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mendus AB (IMMUN)
Track today's live Mendus AB (IMMUN) share price, performance and key data on this page with our current Stockholm:IMMUN stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Mendus AB share price on the Stockholm exchange. Use the dropdown to switch exchange for the IMMUN share price, head to our technical summary section, which provides analysis on Mendus AB share price buy/sell indicators using real-time data (or discuss the Mendus AB (IMMUN) stock price today with other investors in the Mendus AB ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST:IMMUN share price (ISIN: SE0022239950) to enhance your trading decisions with our free investment tools and resources.
What Is the Mendus AB Share Price Today?
The Mendus AB share price today is 6.940.
What Is the Stock Symbol for Mendus AB
The stock symbol (or 'ticker') for Mendus AB is "IMMUN."
What Stock Exchange Does Mendus AB Trade On?
Mendus AB is listed and trades on the Stockholm stock exchange.
Is Mendus AB a Good Stock to Buy?
Determining whether Mendus AB (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ST:IMMUN share price (ISIN: SE0022239950) to enhance your trading decisions with our free investment tools and resources.
What Is the Mendus AB Share Price Today?
The Mendus AB share price today is 6.940.
What Is the Stock Symbol for Mendus AB
The stock symbol (or 'ticker') for Mendus AB is "IMMUN."
What Stock Exchange Does Mendus AB Trade On?
Mendus AB is listed and trades on the Stockholm stock exchange.
Is Mendus AB a Good Stock to Buy?
Determining whether Mendus AB (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Stockholm
Currency in SEK
6.940
+0.010(+0.14%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.820
6.940
52 wk Range
3.860
10.000
IMMUN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.8206.940
52 wk Range
3.86010.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMMUN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
33.000
Upside
+375.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 33.000
(+375.50% Upside)
Earnings
Latest Release
08/05/2026
EPS / Forecast
-0.34 / --
Revenue / Forecast
-- / --
Compare IMMUN to Peers and Sector
Metrics to compare | IMMUN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMMUNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.3x | −2.5x | −0.3x | |
PEG Ratio | −0.18 | −0.10 | 0.00 | |
Price/Book | 0.8x | 4.4x | 2.6x | |
Price / LTM Sales | - | 245.8x | 3.0x | |
Upside (Analyst Target) | 375.5% | 0.0% | 56.7% | |
Fair Value Upside | Unlock | 39.0% | 9.4% | Unlock |
Mendus AB (publ), a biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers. The company’s lead product is vididencel (DCP-001), which is in Phase II ADVANCE-II clinical trial for the treatment of acute myeloid leukemia (AML); Phase 2b CADENCE clinical trial to treat AML; phase 1 clinical trial for the treatment of Vital-CML; and phase 2a clinical trial for the treatment of VITAL-TFR2. It has strategic alliance with NorthX Biologic to support large-scale manufacturing and commercial launch of vididencel. The company was formerly known as Immunicum AB (publ) and changed its name to Mendus AB (publ) in June 2022. Mendus AB (publ) was incorporated in 2002 and is headquartered in Stockholm, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Mendus AB (Stockholm: IMMUN) Share Price Today?
The Mendus AB stock price today is 6.940 SEK.
What Stock Exchange Does Mendus AB (IMMUN) Trade On?
Mendus AB is listed and trades on the Stockholm Stock Exchange.
What Is the Ticker (Stock Symbol) for Mendus AB?
The stock symbol (also called a 'ticker') for Mendus AB is "IMMUN."
What Is the Current Mendus AB Market Capitalisation?
As of today, Mendus AB (Stockholm: IMMUN) market cap is 442.290M SEK.
What Is Mendus AB's (IMMUN) Earnings Per Share (TTM)?
The Mendus AB EPS is currently -1.882 (Trailing Twelve Months).
When Is the Next Mendus AB Earnings Date?
Mendus AB's next earnings report will be released on 20/08/2026.
Is IMMUN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Mendus AB moving averages and other technical indicators, the daily buy/sell signal for IMMUN stock is Strong Buy.
How Many Times Has Mendus AB Stock Split?
Mendus AB has split 4 times. (See the IMMUN stock split history page for full effective split date and price information.)
How Many Employees Does Mendus AB Have?
Mendus AB has 19 employees, based on their latest Companies House report.
What is the current trading status of Mendus AB (Stockholm: IMMUN)?
As of 01/08/2026, Mendus AB (IMMUN) is trading at a share price of 6.940 SEK, with a previous close of 6.930 SEK. The stock has fluctuated within a day range of 6.820 SEK to 6.940 SEK, while its 52-week range spans from 3.860 SEK to 10.000 SEK.
What Is Mendus AB (IMMUN) Price Target According to Analysts?
The average 12-month price target for Mendus AB is 33.000 SEK, with a high estimate of 50 SEK and a low estimate of 16 SEK. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +375.50% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.